Calcium Channel Blockers

Cardiac Electrophysiology Review

Volumn 2, Issue 2, 1998, Pages 218-221

  Wyse, D George ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2342573759     PISSN: 13852264     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009996420245     Document Type: Article

References (19)

1. Wellens HJ, Tan SL, Bar FW, Duren DR, Lie KI, Dohmen HM. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. Br Heart J 1977:39: 1058-1066.
2. Shenasa M, Fromer M, Faugere G, Nadeau R, Leblanc RA, Lambert C, Sadr-Ameli MA. Efficacy and safety of intravenous and oral diltiazem for Wolff-Parkinson-White syndrome. Am J Cardiol 1987;59:301-306.
3. Rizos I, Seidl KH, Aidonidis I, Stamou S, Senges J, Toutouzas P. Intraindividual comparison of diltiazem and verapamil on induction of paroxysmal supraventricular tachycardia. Cardiology 1994;85:388-396.
4. Yeh SJ, Kow HC, Lin FC, Hung JS, Wu D. Effects of oral diltiazem in paroxysmal supraventricular tachycardia. Am J Cardiol 1983;52:271-278.
5. Tonkin AM, Aylward PE, Joel SE, Heddle WF. Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia. J Cardiovasc Pharmacol 1980;2:473-486.
6. Klein HO, Pauzner H, Di Segni E, David D, Kaplinsky E. The beneficial effects of verapamil in chronic atrial fibrillation. Arch Intern Med 1979;139:747-749.
7. Koh KK, Song JH, Kwon KS, Park HB, Baik SH, Park YS, In HH, Moon TH, Park GS, Cho SK. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study. Int J Cardiol 1995;52:167-174.
8. Brignole M, Gianfranchi L, Menozzi C, Alboni P, Musso G, Bongiorni MG, Gasparini M, Raviele A, Lolli G, Paparella N, Accquarone S. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. A randomized controlled study. Circulation 1997;96:2617-2624.
9. Shenasa M, Kus T, Fromer M, LeBlanc RA, Dubuc M, Nadeau R. Effect of intravenous and oral calcium antagonists (diltiazem and verapamil) on sustenance of atrial fibrillation. Am J Cardiol 1988;62:403-407.
10. Wijffels MC, Kirchof CJ, Dorland R, Allessie MA. AF begets AF: A study in awake chronically instrumented goals. Circulation 1995;92:1954-1968.
11. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996;94:2968-2974.
12. Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Stickberger SA, Morady F. Effect of atrial fibrillation of atrial refractoriness in humans. Circulation 1996;94:1600-1606.
13. Tieleman RF, DeLangen C, Van Gelder IC, deKam PJ, Grandjean J, Bel KJ, Wijffels MC, Allessie MA, Crijns HJ. Verapamil reduces tachycardia-induced electrical remodeling of the atrial. Circulation 1997;95:1945-1953.
14. Daoud EF, Knight BP, Weiss R, Bahu M, Paladino W, Goyal R, Man KC, Strickberger SA, Morady F. Effect of verapamil and procainamide on atrial fibrillation-induced electrical remodeling in humans. Circulation 1997;96:1542-1550.
15. Tieleman RG, Van Gelder IC, Crijns HJ, DeKam PJ, Van Den Berg MP, Haaksma J, Van Der Woude HJ, Allessie MA. Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria. J Am Coll Cardiol 1998;31:167-173.
16. Timmermans C, Rodriguez LM, Smeets JL, Wellens H. Immediate reinitiation of atrial fibrillation following internal atrial defibrillation. J Cardiovasc Electrophysiol 1998;9: 122-128.
17. Wellens HJ. Value and limitation of programmed electrical stimulation of the heart in the study and treatment of tachycardias. Circulation 1978;57:845-853.
18. Vaage-Nilsen M, Hansen JF, Mellemgaard K, Hagerup L, Sigurd B, Steinmetz E. Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II). Int J Cardiol 1995;48:255-258.
19. Lee SH, Chen SA, Tai CT, Chiang CE, Wu TJ, Cheng CC, Chiou CW, Ueng KC, Wang SP, Chiang BN, Chang MS. Electropharmacologic characteristics and radiofrequency catheter ablation of sustained ventricular tachycardia in patients without structural heart disease. Cardiology 1996; 87:33-41.